home / stock / shrmf / shrmf news


SHRMF News and Press, Champignon Brands From 10/05/20

Stock Information

Company Name: Champignon Brands
Stock Symbol: SHRMF
Market: OTC

Menu

SHRMF SHRMF Quote SHRMF Short SHRMF News SHRMF Articles SHRMF Message Board
Get SHRMF Alerts

News, Short Squeeze, Breakout and More Instantly...

SHRMF - Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc. Canada NewsWire VANCOUVER, BC, Oct. 5, 2020 VANCOUVER, BC , Oct. 5, 2020 /CNW/ - Dr. Roger McIntyre has been elected Chairman of the Board of Directors of Champignon Brands Inc. (" Ch...

SHRMF - PsychedelicNewsBreaks - Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Issues Update Regarding Ongoing Disclosure Review

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) continues to work with the British Columbia Securities Commission to address an ongoing continuous disclosure review. According to the update, the company has arranged for the following since the review commenced: Filing of business acq...

SHRMF - Champignon Provides Update on Disclosure Review

VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (CSE: SHRM) (the “ Company ”) continues to work with the British Columbia Securities Commission (the “ Commission ”) to address an ongoing continuous disclosure review.  S...

SHRMF - Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market

September 15, 2020 Palm Beach, FL – September 15, 2020 – Investors are seeing big opportunity in psychedelics based upon the numbers that the nascent cannabis industry has been putting up… after all, last year, worldwide sales of legal cannabis re-accelerated ...

SHRMF - PsychedelicNewsBreaks - Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) to Offer Esketamine for Treatment of Adults with MDD at Flagship Clinic

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) , today announced that it is expanding its rapid-onset treatment service for major depressive disorder (“MDD”). According to the update, Champignon will offer esketamine for the treatment of adults with MDD at its flagship ...

SHRMF - Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence

VANCOUVER, British Columbia, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (CSE: SHRM) (the “ Company ” or “ Champignon ”) is expanding its rapid-onset treatment service for major depressive disorder (“ MDD ”).  Champignon will offer...

Previous 10 Next 10